Collard Craig A

Number of records: 31
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
19-Apr-24 4:34 PM
View: 
AP Pharma Inc. (HRTX) 19-Apr-24Option Exercise 13,797----6%
249.0K to 262.79K
05-Apr-24 3:57 PM
View: 
AP Pharma Inc. (HRTX) 03-Apr-24Option Exercise 62,500----34%
186.5K to 249.0K
17-Nov-23 12:37 PM
View: 
AP Pharma Inc. (HRTX) 16-Nov-23Private Purchase 150,000$0.92$137,970.00411%
36.5K to 186.5K
24-Aug-23 4:09 PM
View: 
AP Pharma Inc. (HRTX) 22-Aug-23Payment of Exercise 692$1.65$1,141.80(2%)
37.19K to 36.5K
26-Jun-23 2:40 PM
View: 
Terrascend Corp. (TSNDF) 22-Jun-23Grant 132,647----32%
420.87K to 553.51K
24-May-23 5:04 PM
View: 
AP Pharma Inc. (HRTX) 22-May-23Payment of Exercise 691$1.45$1,001.95(2%)
37.88K to 37.19K
03-Mar-23 9:25 AM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 02-Mar-23Disposition 55,822$20.00$1,116,440.00(100%)
55.82K to 0
27-Sep-22 12:00 PM
View: 
Terrascend Corp. (TSNDF) 23-Sep-22Purchase 60,000----17%
360.87K to 420.87K
26-Sep-22 12:26 PM
View: 
Terrascend Corp. (TSNDF) 22-Sep-22Purchase 120,000----50%
240.87K to 360.87K
01-Jul-22 4:37 PM
View: 
Sierra Oncology, Inc. (SRRA) 01-Jul-22Disposition 13,500$55.00$742,500.00(100%)
13.5K to 0
29-Jun-22 9:08 PM
View: 
Terrascend Corp. (TSNDF) 27-Jun-22Grant 114,414----90%
126.45K to 240.87K
14-Jun-22 5:00 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 14-Jun-22Grant 2,000----4%
53.82K to 55.82K
13-Jun-22 4:55 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 13-Jun-22Purchase 4,037$10.94$44,148.608%
49.78K to 53.82K
13-Jun-22 4:55 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 10-Jun-22Private Purchase 1,663$11.50$19,117.803%
48.12K to 49.78K
17-May-22 4:02 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 16-May-22Private Purchase 27,150$13.54$367,611.00129%
20.97K to 48.12K
16-May-22 4:05 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 13-May-22Private Purchase 3,689$10.49$38,697.6021%
17.28K to 20.97K
10-Jan-22 9:30 PM
View: 
Terrascend Corp. (TSNDF) 06-Jan-22Exercise (in-the money or at-the-money) 52,939$2.54$134,465.0072%
73.51K to 126.45K
24-Nov-21 7:07 PM
View: 
Sierra Oncology, Inc. (SRRA) 24-Nov-21Market Purchase 7,899$23.08$182,348.00141%
5.6K to 13.5K
(< 1%)
24-Nov-21 7:07 PM
View: 
Sierra Oncology, Inc. (SRRA) 23-Nov-21Market Purchase 5,601$22.94$128,515.00100%
0 to 5.6K
< 1%
15-Sep-21 4:01 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 13-Sep-21Grant 1,206$18.02$21,736.809%
13.58K to 14.78K
8%
15-Sep-21 4:01 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 13-Sep-21Market Purchase 2,500$18.13$45,325.0017%
14.78K to 17.28K
7%
13-Sep-21 4:08 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 10-Sep-21Market Purchase 9,577$18.18$174,110.00239%
4.0K to 13.58K
(< 1%)
16-Jun-21 4:01 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 15-Jun-21Grant 2,000----100%
2.0K to 4.0K
15-Jun-20 4:05 PM
View: 
Opiant Pharmaceuticals, Inc. (OPNT) 15-Jun-20Grant 2,000----100%
0 to 2.0K
04-Feb-14 10:58 AM
View: 
Critical Therapeutics Inc. (CRTX) 03-Feb-14Disposition 1,567,220$9.50$14,888,600.00(97%)
1.61M to 45.0K
(< 1%)
04-Feb-14 10:58 AM
View: 
Critical Therapeutics Inc. (CRTX) 03-Feb-14Disposition 45,000$9.50$427,500.00(100%)
45.0K to 0
(< 1%)
07-Mar-13 4:12 PM
View: 
Critical Therapeutics Inc. (CRTX) 05-Mar-13Grant 45,000----3%
1.57M to 1.61M
03-Apr-12 4:14 PM
View: 
Critical Therapeutics Inc. (CRTX) 03-Apr-12Market Sale 1,443,910$6.25$9,024,460.00(48%)
3.01M to 1.57M
2%
20-Dec-10 6:32 PM
View: 
Critical Therapeutics Inc. (CRTX) 16-Dec-10Market Sale 385,000$6.02$2,317,700.00(11%)
3.4M to 3.01M
2%
30-Jul-09 11:53 AM
View: 
Critical Therapeutics Inc. (CRTX) 28-Jul-09Sale
Duplicate
1,250,000$5.50$6,875,000.00(27%)
4.65M to 3.4M
04-Nov-08 7:50 PM
View: 
Critical Therapeutics Inc. (CRTX) 31-Oct-08Grant 4,646,140----145%
3.2M to 7.85M